CD79A and nasopharyngeal carcinoma: For example, mucosa-specific antibodies (IgA) against EBV proteins, such as EBNA1 and VCA viral capsid antigen (VCA) p18 and systemic antibodies (IgG) against BNLF2b can distinguish healthy individuals from those with early-stage NPC (2, 4, 5).